Publications
5674 Results
- Journal / Conference
- ASCO Annual Meeting (May 30 to June 3, 2025, Chicago, Il), poster, Abstract # 2600 Poster Bd # 247
- Year
- 2025
- Research Committee(s)
- Symptom Management and Survivorship
- Study Number(s)
- S2013
Baseline autoimmune diseases and characteristics of solid tumor patients on immune checkpoint inhibitor (ICI) therapy enrolled in a prospective study of immune-related adverse events (irAEs): SWOG S2013 (I-CHECKIT)
- Journal / Conference
- ASCO Annual Meeting (May 30 to June 3, 2025, Chicago, Il), poster; Abstract # 2619 Poster Bd # 266
- Year
- 2025
- Research Committee(s)
- Early Therapeutics and Rare Cancers
- Study Number(s)
- S1609
Efficacy and Toxicity of Nivolumab and Ipilimumab in Rare Cancer Brain Metastases: A Multi-Center Basket Trial Analysis (NCI/SWOG S1609)
- Journal / Conference
- ASCO Annual Meeting (May 30 to June 3, 2025, Chicago, Il), publication only, Abstract # e17111
- Year
- 2025
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S1802
Combined genomic profiling of cell-free DNA (cfDNA) and circulating tumor cell DNA (ctcDNA) in S1802, a prospective phase 3 trial for metastatic prostate cancer (mHSPC)
- Journal / Conference
- ASCO Annual Meeting (May 30 to June 3, 2025, Chicago, Il), rapid oral, Abstract # 11016
- Year
- 2025
- Research Committee(s)
- Lung
- Study Number(s)
- S2302
SWOG S2302, PRAGMATICA-LUNG: A Pragmatic Trial Designed to Increase Participant Representation
- Journal / Conference
- ASCO Annual Meeting (May 30 to June 3, 2025, Chicago, Il), oral, Abstract # 8003
- Year
- 2025
- Research Committee(s)
- Lung
- Study Number(s)
- S1914
SWOG/NRG S1914: A Randomized Phase III Trial of Induction/Consolidation Atezolizumab + SBRT versus SBRT Alone in High Risk, Early-Stage NSCLC
- Journal / Conference
- ASCO Annual Meeting (May 30 to June 3, 2025, Chicago, Il), poster; Abstract # TPS8113 Poster Bd # 234a
- Year
- 2025
- Research Committee(s)
- Lung
- Study Number(s)
- CTSU/A082304/S2402
Comparing impact of treatment before or after surgery in patients with stage II-IIIb resectable non-small cell lung cancer (NSCLC; Alliance A082304-SWOG S2402).
- Journal / Conference
- World Congress of Endourology (Sept 8-12, 2025, Phoenix, AZ)
- Year
- 2025
- Research Committee(s)
- Cancer Control
- Study Number(s)
- SWOG-9217
Urinary outcomes of International Prostate Symptom Score phenotypes following transurethral resection of the prostate: a secondary analysis of the Prostate Cancer Prevention Trial
- Journal / Conference
- ISOQOL Meeting (22-25 October 2025 Milwaukee, WI)
- Year
- 2025
- Research Committee(s)
- Palliative Care
- Study Number(s)
- S1316
Patient-reported outcomes (PROs) in the pragmatic comparative effectiveness trial of surgical versus non-surgical management for patients with malignant bowel obstruction (S1316)
- Journal / Conference
- Pharmacogenomics Research Network (PGRN) 2025 Annual Meeting (September 10-12, 2025, Mkssoula, MT)
- Year
- 2025
- Research Committee(s)
- Breast
- Study Number(s)
- S0221
EXTERNAL VALIDATION OF A POLYGENIC RISK SCORE FOR TAXANE-INDUCED PERIPHERAL NEUROPATHY: RESULTS FROM THE SWOG S0221 CLINICAL TRIAL
- Journal / Conference
- ASTRO Annual Meeting (9/27 to 10/1/2025, San Francisco, CA), oral, Abstract #: 68808
- Year
- 2025
- Research Committee(s)
- Breast
- Study Number(s)
- S1706